Our chart of the month shows ATEC’s sales by product segment over a 10-year period from 2017 to 2026 (based on the guidance provided by the company in 4Q 2025). ATEC has an astonishing 25% CAGR over that period.
Sales bottomed out in 2018 at just under $92 million, but CEO Pat Miles and his leadership team have rebuilt the company into one of the industry’s best growth stories and an aggressive share-taker in the spine market.
“I think the market has been healthy and has felt healthy,” said ATEC CFO Todd Koning. “That’s a good thing. We feel that when you look at our growth and you look at our size, clearly, we’re taking share from all the major players. You don’t grow $40-plus million year-over-year without touching all the competitors.”
To fully compete with spine’s major players, however, ATEC will have to continue building out its enabling technology portfolio. SafeOp and EOS have provided a nice base, but ATEC could be entering a new phase of competition as its Valence robot ramps up to full release.
ATEC expects the system to bring a new level of efficiency to experienced surgeons, but also create a more predictable and accessible experience for a broader surgeon audience.
ATEC Segment Sales by Year
Our chart of the month shows ATEC's sales by product segment over a 10-year period from 2017 to 2026 (based on the guidance provided by the company in 4Q 2025). ATEC has an astonishing 25% CAGR over that period.
Sales bottomed out in 2018 at just under $92 million, but CEO Pat Miles and his leadership team...
ATEC Segment Sales by Year
Our chart of the month shows ATEC’s sales by product segment over a 10-year period from 2017 to 2026 (based on the guidance provided by the company in 4Q 2025). ATEC has an astonishing 25% CAGR over that period.
Sales bottomed out in 2018 at just under $92 million, but CEO Pat Miles and his leadership team have rebuilt the company into one of the industry’s best growth stories and an aggressive share-taker in the spine market.
“I think the market has been healthy and has felt healthy,” said ATEC CFO Todd Koning. “That’s a good thing. We feel that when you look at our growth and you look at our size, clearly, we’re taking share from all the major players. You don’t grow $40-plus million year-over-year without touching all the competitors.”
To fully compete with spine’s major players, however, ATEC will have to continue building out its enabling technology portfolio. SafeOp and EOS have provided a nice base, but ATEC could be entering a new phase of competition as its Valence robot ramps up to full release.
ATEC expects the system to bring a new level of efficiency to experienced surgeons, but also create a more predictable and accessible experience for a broader surgeon audience.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
